
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with CME from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/cme/topic/2004/</link>
        <description>Articles tagged with CME from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>BI, Lilly go simple in new SGLT med-ed effort</title>
          <description>Boehringer Ingelheim and Eli Lilly rolled out a pre-launch SGLT campaign that breaks ranks with branding for J&amp;J&apos;s SGLT2 inhibitor Invokana.</description>
          <link>http://www.mmm-online.com/bi-lilly-go-simple-in-new-sglt-med-ed-effort/article/292257/</link>
          <pubDate>Tue, 07 May 2013 14:03:31 GMT</pubDate>
          <itunes:summary>Boehringer Ingelheim and Eli Lilly rolled out a pre-launch SGLT campaign that breaks ranks with branding for J&amp;J&apos;s SGLT2 inhibitor Invokana.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Navidea deploying MSLs in launch of new diagnostic agent</title>
          <description>Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.</description>
          <link>http://www.mmm-online.com/navidea-deploying-msls-in-launch-of-new-diagnostic-agent/article/291661/</link>
          <pubDate>Thu, 02 May 2013 16:15:10 GMT</pubDate>
          <itunes:summary>Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Sunshine spawns fresh questions for med ed</title>
          <description>New transparency rules set to lay bare financial ties between physicians and pharma will be a mixed bag for medical education, providers say.</description>
          <link>http://www.mmm-online.com/sunshine-spawns-fresh-questions-for-med-ed/article/280966/</link>
          <pubDate>Tue, 19 Feb 2013 20:40:16 GMT</pubDate>
          <itunes:summary>New transparency rules set to lay bare financial ties between physicians and pharma will be a mixed bag for medical education, providers say.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>CMS releases &quot;Sunshine&quot; final rule: federal preemption, August start date</title>
          <description>CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.</description>
          <link>http://www.mmm-online.com/cms-releases-sunshine-final-rule-federal-preemption-august-start-date/article/278783/</link>
          <pubDate>Fri, 01 Feb 2013 21:20:35 GMT</pubDate>
          <itunes:summary>CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>M3 Group extends reach in Iberian and Latin American markets with partnership</title>
          <description>MDLinx owner M3 Group is partnering with Argentine online CME firm Medcenter on a content-sharing deal that will expand its in-language reach to Spain, Portugal and Latin America.</description>
          <link>http://www.mmm-online.com/m3-group-extends-reach-in-iberian-and-latin-american-markets-with-partnership/article/273766/</link>
          <pubDate>Fri, 21 Dec 2012 19:16:15 GMT</pubDate>
          <itunes:summary>MDLinx owner M3 Group is partnering with Argentine online CME firm Medcenter on a content-sharing deal that will expand its in-language reach to Spain, Portugal and Latin America.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pri-Med in deal to buy EHR firm</title>
          <description>The med-ed company is buying Amazing Charts, a tie-up the firms say will enable them to deliver customized education to physicians and then assess the patient-level impact.</description>
          <link>http://www.mmm-online.com/pri-med-in-deal-to-buy-ehr-firm/article/268960/</link>
          <pubDate>Mon, 19 Nov 2012 18:53:41 GMT</pubDate>
          <itunes:summary>The med-ed company is buying Amazing Charts, a tie-up the firms say will enable them to deliver customized education to physicians and then assess the patient-level impact.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Most docs don&apos;t know about FDA&apos;s opioid safety plan: survey</title>
          <description>Only 35% of physicians are aware of the FDA&apos;s class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.</description>
          <link>http://www.mmm-online.com/most-docs-dont-know-about-fdas-opioid-safety-plan-survey/article/259012/</link>
          <pubDate>Mon, 17 Sep 2012 13:00:00 GMT</pubDate>
          <itunes:summary>Only 35% of physicians are aware of the FDA&apos;s class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Sunshine Act could scare docs away from commercially-supported CME</title>
          <description>Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.</description>
          <link>http://www.mmm-online.com/sunshine-act-could-scare-docs-away-from-commercially-supported-cme/article/258904/</link>
          <pubDate>Thu, 13 Sep 2012 18:01:28 GMT</pubDate>
          <itunes:summary>Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharma slashed CME funding again last year: report</title>
          <description>The drug industry dialed back its continuing medical education (CME) grant-giving in 2011, continuing a negative trend of the last few years.</description>
          <link>http://www.mmm-online.com/pharma-slashed-cme-funding-again-last-year-report/article/251878/</link>
          <pubDate>Wed, 25 Jul 2012 18:08:06 GMT</pubDate>
          <itunes:summary>The drug industry dialed back its continuing medical education (CME) grant-giving in 2011, continuing a negative trend of the last few years.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>People news: ACEHP and Preventice</title>
          <description>The Alliance for Continuing Education in the Health Professions (ACEHP) named a new executive director, and mobile health app firm Preventice hired a director of global business development.</description>
          <link>http://www.mmm-online.com/people-news-acehp-and-preventice/article/251413/</link>
          <pubDate>Mon, 23 Jul 2012 19:04:12 GMT</pubDate>
          <itunes:summary>The Alliance for Continuing Education in the Health Professions (ACEHP) named a new executive director, and mobile health app firm Preventice hired a director of global business development.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  